MYLUNG Consortium Part 3: Observational Study

Part of paid clinical trials in Daphne, Alabama.

Sponsor
US Oncology Research
Study ID
NCT05885698
Status
Recruiting
Apply to this trial

Conditions

  • Carcinoma, Non-Small-Cell Lung

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.

Key Dates

Start date
Jan 30, 2023
Status verified
May 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
7,500 participants (estimated)

Arms

  • Arm: Non-small Cell Lung Cancer

Primary Outcome Measure

Proportion of Patients Who Receive Biomarker Test Results Prior to Systemic Therapy or Death [ Time Frame: 5 years from date of enrollment into study ]

Central Contacts

Locations (17)

FacilityCityStateZIPSite coordinators
Southern Cancer Center, PCDaphneAlabama36526
Karla Childers
[email protected]
251-433-9899
Michael Meshad, MD (PRINCIPAL_INVESTIGATOR)
Arizona Oncology Associates, PC - NAHOAPrescott ValleyArizona86314
Erika Arguello Vargas
[email protected]
928-775-9430
Allan V. Espinosa Morazan, MD (PRINCIPAL_INVESTIGATOR)
Rocky Mountain Cancer CenterDenverColorado80218-
Cancer Care Centers of Brevard, Inc.Palm BayFlorida32901
Karla Childers
[email protected]
251-433-9899
Venkat Pavan R. Kancharla, MD (PRINCIPAL_INVESTIGATOR)
Woodlands Medical Specialists, PAPensacolaFlorida32503-
Affiliated Oncologists, LLCChicago RidgeIllinois60415
Angela Malone
[email protected]
708-424-9710
Rami Y. Haddad, MD (PRINCIPAL_INVESTIGATOR)
Illinois Cancer SpecialistsNilesIllinois60714-
Maryland Oncology Hematology, P.A.Silver SpringMaryland20904-
Minnesota Oncology Hematology, P.A.MinneapolisMinnesota55404-
New York Oncology Hematology, P.C.AlbanyNew York12208
Ambri Cicchinelli
[email protected]
518-262-6696
Makenzi Evangelist, MD (PRINCIPAL_INVESTIGATOR)
Oncology Hematology Care Clinical Trials, LLCCincinnatiOhio45242
Sara Gonce
[email protected]
513-751-2273
Patrick J. Ward, MD (PRINCIPAL_INVESTIGATOR)
Willamette Valley Cancer Institute and Research CenterEugeneOregon97401
Jeanne Schaffer
[email protected]
541-683-5001
James E. Butrynski, MD (PRINCIPAL_INVESTIGATOR)
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer CareBlacksburgVirginia24060
Natasha R. Holt
[email protected]
540-982-0237
Jerome H. Goldschmidt, Jr., MD (PRINCIPAL_INVESTIGATOR)
Virginia Cancer Specialists, PCFairfaxVirginia22031-
Virginia Oncology AssociatesNewport NewsVirginia23606
Ebony Villarson
[email protected]
757-873-9810
John C. Paschold, MD (PRINCIPAL_INVESTIGATOR)
Shenandoah Oncology, P.C.WinchesterVirginia22601-
Northwest Cancer Specialists, P.C.VancouverWashington98684
Julian Kern
[email protected]
360-597-1300
Anthony Van Ho, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Daphne, AL

By research site
Southern Cancer Center, PC· Daphne, ALArizona Oncology Associates, PC - NAHOA· Prescott Valley, AZRocky Mountain Cancer Center· Denver, COCancer Care Centers of Brevard, Inc.· Palm Bay, FLWoodlands Medical Specialists, PA· Pensacola, FLAffiliated Oncologists, LLC· Chicago Ridge, IL

Related Studies